FTO (also referred to as ALKBH9) was first identified as an obesity-related gene; it exhibits dioxygenase activity that oxidizes m6A to form an N6-hydroxymethyladenosine intermediate, which is further oxidized to N6-formyladenosine. The gene discussed is FTO; the disease is Obesity.